What is it about?
Foot disease is a serious problem for people with diabetes. The International Working Group on the Diabetic Foot (IWGDF) has been creating guidelines for almost 30 years to help healthcare providers worldwide prevent and manage diabetes-related foot issues. This publication aims to explain the history of the IWGDF Guidelines, describe the latest update from 2023, and highlight the efforts involved in creating and translating these guidelines. By understanding the story behind the IWGDF Guidelines, readers can better use the recommendations to improve care for patients with diabetes-related foot disease.
Featured Image
Photo by Lucas Sankey on Unsplash
Why is it important?
Diabetes-related foot disease can lead to severe complications, including amputations, which greatly affect patients' lives. The IWGDF Guidelines provide evidence-based strategies to prevent and manage these issues, helping healthcare providers deliver better care to their patients. By knowing the history and efforts behind these guidelines, healthcare professionals can appreciate the importance of implementing them and understand the global collaboration involved in their development. Key Takeaways: 1. The IWGDF Guidelines have been providing guidance on managing diabetes-related foot disease for nearly three decades. 2. The latest update in 2023 includes practical guidelines, systematic reviews, and definitions documents, reflecting ongoing efforts to improve care. 3. Creating and updating these guidelines involves significant time and effort from experts worldwide, with an estimated cost of 2 million euros if done commercially. 4. Translations of the IWGDF Guidelines make them accessible to billions of people globally, supporting their implementation in diverse communities. 5. Understanding the history and development of the IWGDF Guidelines can help healthcare providers better utilize them to reduce the burden of diabetes-related foot disease.
Read the Original
This page is a summary of: The International Working Group on the Diabetic Foot: Stories and Numbers Behind Three Decades of Evidence-Based Guidelines for the Management of Diabetes-Related Foot Disease, Diabetes Therapy, November 2023, Springer Science + Business Media,
DOI: 10.1007/s13300-023-01510-5.
You can read the full text:
Contributors
Be the first to contribute to this page







